ESMO - Eur. Oncology· @myESMO · X·· 1 天前评分70
正文 · 原文
#ESMO26: Adding capivasertib to abiraterone and adding abiraterone to standard care resulted in significant improvements in #ProstateCancer in the phase III CAPItello-281 and PEACE-1 #ClinicalTrials, as discussed by Elena Castro
🔗 https://ow.ly/k8xU50ZZk08
#InsightsbyESMO
264 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
Capivasertib (capi) + abiraterone (abi) vs placebo (pbo) + abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC): Updated overall survival (OS) from CAPItello-281
https://esmocongress.esmo.org来源：ESMO - Eur. Oncology · x.com